Ignite Creation Date:
2024-05-05 @ 10:39 PM
Last Modification Date:
2024-10-26 @ 10:21 AM
Study NCT ID:
NCT01151423
Status:
COMPLETED
Last Update Posted:
2023-04-04
First Post:
2010-06-25
Brief Title:
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor vWF Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura aTTP
Sponsor:
Ablynx a Sanofi company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01
Start Date Type:
ACTUAL
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-25
First Submit QC Date:
June 25 2010
Study First Post Date:
2010-06-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-05-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2015-06-29
Disp First Submit QC Date:
June 29 2015
Disp First Post Date:
2015-07-22
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2023-03-31
Last Update Post Date:
2023-04-04
Last Update Post Date Type:
ACTUAL